FI-LAB
5 papers8 findings
Human studies report FI-LAB prediction of mortality in emergency department patients and critically ill acute ischaemic stroke patients at a 24-hour landmark. A preprint reports improved mortality discrimination within MIMIC-IV, while a review describes prediction of 12-month mortality after endovascular therapy for acute ischaemic stroke.
- Humans4
Effects
1Mortality discrimination
upin humans1
1 study
Mortality discrimination
upin humans1
FI-LAB improves mortality discrimination in humans (+0.0132 AUC (95% CI 0.0081 to 0.0184)).
Humansinternally in MIMIC-IV patients
Research Square16 Sep 2026Preprint
Associations
6Mortality
upin humans2HR 2.04
2 studies
Mortality
upin humans2HR 2.04
FI-LAB predicts mortality in humans (AUC 0.774 to 0.808).
Humanscritically ill acute ischemic stroke patients at 24-h landmarkn = 1,296
Frontiers in neurology3 Sep 2026
FI-LAB predicts mortality in humans (HR 2.04, 95% CI 1.99–2.09).
Humansin emergency department patients (MIMIC-IV-ED)
PLoS medicine1 Sep 2026
12-month mortality
upin humans1HR 3.61
1 study
12-month mortality
upin humans1HR 3.61
FI-LAB predicts 12-month mortality in humans (adjusted HR 3.61, 95% CI 1.98-6.61).
Reviewafter endovascular therapy for acute ischaemic stroke
Cureus19 Aug 2026
Malignant arrhythmia
upin humans1
1 study
Malignant arrhythmia
upin humans1
FI-LAB raises the risk of malignant arrhythmia in humans (SHR = 2.68, 95% CI: 1.39-5.18).
Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)
Science progress11 Aug 2026
1-year mortality
upin humans1HR 3.6
1 study
1-year mortality
upin humans1HR 3.6
FI-LAB raises the risk of 1-year mortality in humans (HR = 3.60, 95% CI: 2.56-5.06).
Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)
Science progress11 Aug 2026
28-day mortality
upin humans1HR 3.42
1 study
28-day mortality
upin humans1HR 3.42
FI-LAB raises the risk of 28-day mortality in humans (HR = 3.42, 95% CI: 2.17-5.40).
Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)
Science progress11 Aug 2026
In-hospital mortality
upin humans1OR 4.41
1 study
In-hospital mortality
upin humans1OR 4.41
FI-LAB raises the risk of in-hospital mortality in humans (OR = 4.41, 95% CI: 2.60-7.48).
Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)
Science progress11 Aug 2026